The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It cut drug costs by billions but also opened doors to patent abuse.
VIEW MOREGeneric drugs save up to 85% on costs and work just as well as brand-name versions. Learn how the FDA ensures they're safe, why they look different, and when you might notice a difference.
VIEW MOREBioequivalence testing ensures generic drugs work just like brand-name ones. Learn how this science protects patient safety, saves billions, and makes affordable medicine possible.
VIEW MOREThe FDA now conducts unannounced inspections of foreign generic drug factories to close a safety gap. Learn how CGMP standards, new inspection rules, and global supply chains affect the medicines you take every day.
VIEW MORE